InsidersTradesSigma
Follow the 迈普医学 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 迈普医学 has published 6 insider filings. Market capitalisation: €4.2bn. The latest transaction was filed on 22 May 2024 (Purchase). Among the most active insiders: 袁美福. The full history is free.
6
Insider Decl.
n/a
Thresholds
€147,359
4 ops.
Buy Volume
€1m
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,133 of 29,063 companies
64.3
score / 100
Value39
Quality89
FCF yld2.8%
Earn yld2.7%
EV/EBITDA27.0x
ROE14%
Gross mgn80%
Net mgn31%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 May 2024
Declarations6 total
6 of 6 declarations
Acerca de 迈普医学
迈普医学 es una empresa especializada en el sector de la salud y farmacéutico, que ofrece soluciones innovadoras para el diagnóstico y el tratamiento. Cotiza en el mercado XSHE.